Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Washington: U.S. health officials said Wednesday they have agreed to purchase another 105 million doses of Pfizer's COVID-19 vaccine in anticipation of a fall...
Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Washington: U.S. health officials said Wednesday they have agreed to purchase another 105 million doses of Pfizer's COVID-19 vaccine in anticipation of a fall...
Zurich - Novartis said it has resumed production and delivery of radioligand therapy drugs after addressing issues that led to a temporary suspension of...
AstraZeneca said on Thursday that the combination of its cancer drug Imfinzi and chemotherapy showed promise in late-stage trials in patients with aggressive lung...
The Canadian province of British Columbia said on Wednesday it had reached a C$150 million ($116.50 million) settlement with OxyContin maker Purdue Pharma Canada...
Ahmedabad: Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide for Injection USP, 200mg/20mL (10mg/mL)...
Recent Comments